Eye Hospital Pristina Kosovo
13
0
5
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Human Fresh Corneal Lenticule Implantation Criteria in Progressive Corneal Disease Using Relex-Smile
Role: lead
Treatment of Residual Hypermetropic Refraction on Pseudophakic Patients Using Allogenic Fresh Myopic Lenticule
Role: lead
Treatment of Residual Refraction Errors 6 Months After Trifocal IOL Implantation With Relex-Smile
Role: lead
A New Successful Approach for Emmetropic Presbyopic Patients Using Intrastromal Pocket With Smile Module
Role: lead
Intrastromal Fresh Human Corneal Lenticule Implantation Using Smile Surgery for Treatment of Irregular Corneal Astigmatism After Penetrating Keratoplasty (New Approach)
Role: lead
Fresh Corneal Lenticule Implantation in Hyperopic Patients With High Astigmatism
Role: lead
Stromal Lenticule Implantation for Management of Herpetic Stromal Keratitis
Role: lead
Fresh Corneal Lenticule Implantation in Macular Corneal Distrophy With Relex Smile Surgery
Role: lead
Lenticule Implantation and Autologous Serum New Approach in Treatment of Adenoviral Keratitis Disease
Role: lead
Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile
Role: lead
Fresh Corneal Lenticule Implantation and Autologous Serum - Case Report
Role: lead
Treatment of Residual Hypermetropic Refraction on Young Patients After LASIK Using Human Fresh Corneal Lenticule Implantation With ReLEX Smile Surgery
Role: lead
Toric Trifocal IOL Treatment With High Astigmatism and Hyperopia vs SMILE Enhancement After Trifocal IOL Treatment
Role: lead
All 13 trials loaded